TY  - GEN
AU  - Martinelli,Erika
AU  - Troiani,Teresa
AU  - Morgillo,Floriana
AU  - Rodolico,Gabriella
AU  - Vitagliano,Donata
AU  - Morelli,Maria Pia
AU  - Tuccillo,Concetta
AU  - Vecchione,Loredana
AU  - Capasso,Anna
AU  - Orditura,Michele
AU  - De Vita,Ferdinando
AU  - Eckhardt,S Gail
AU  - Santoro,Massimo
AU  - Berrino,Liberato
AU  - Ciardiello,Fortunato
TI  - Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells
SN  - 1557-3265
PY  - 2010///1214
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Benzenesulfonates
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Growth Processes
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - Drug Synergism
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - HCT116 Cells
KW  - HT29 Cells
KW  - Humans
KW  - Lung Neoplasms
KW  - Mice
KW  - Mice, Nude
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Quinazolines
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - biosynthesis
KW  - Signal Transduction
KW  - Sorafenib
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-10-0923
ER  -